SCHEMBL7733055

SCHEMBL7733055

CN(C)CC(C(O)c1ccc2nc(N)sc2c1)N1CCC(Cc2ccccc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 6/20 0.44
ADRA2A P08913 5/20 0.44
HTR2A P28223 5/20 0.44
ADRA1A P35348 5/20 0.44
HTR2B P41595 4/20 0.44
GRIN1 Q05586 4/20 0.44
SIGMAR1 Q99720 3/20 0.44
GRIN2D O15399 2/20 0.44
HTR1A P08908 2/20 0.44
GRIN2A Q12879 2/20 0.44
GRIN2C Q14957 2/20 0.44
RAB9A P51151 2/20 0.44
LMNA P02545 1/20 0.44
ADRB1 P08588 1/20 0.44
DRD2 P14416 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
HRH1 P35367 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7736139 0.90 GRIN2B (0.44) GRIN2BADRA2AHTR2AADRA1AHTR2B
SCHEMBL7731629 0.87 GRIN2B (0.60) GRIN2BADRA2AHTR2AADRA1AHTR2B
SCHEMBL7723321 0.86 DRD4 (0.46) GRIN2BADRA2AHTR2AADRA1AHTR2B
SCHEMBL7732684 0.85 GRIN2B (0.40) GRIN2BADRA2AHTR2AADRA1AHTR2B
SCHEMBL7732339 0.83 CYP2C9 (0.49) RAB9ALMNACYP3A4CYP2D6GAA
SCHEMBL7733873 0.82 CYP2D6 (0.41) GRIN2BADRA2AHTR2AADRA1AHTR2B
SCHEMBL7735957 0.81 GRIN2B (0.57) GRIN2BADRA2AHTR2AADRA1AHTR2B
SCHEMBL7736257 0.80 ALDH1A1 (0.52) RAB9ALMNACYP1A2CYP3A4CYP2D6
SCHEMBL8125450 0.76 NPC1 (0.45) RAB9ADRD2KCNH2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL7733933 0.76 NPC1 (0.44) RAB9ADRD2KCNH2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407122-B1 NEUROPROTECTIVE AGENTS, ANTIISCHEMIC, AND HYPERGLYCEMIC AGENTS; HUNTINGTON*S, PARKINSON*S, AND ALZHEIMER*S DISEASE;AMYOTROPHIC LATERAL SCLEROSIS TREATMENT; NERVOUS SYSTEM AND BRAIN DISORDERS PHARMACIA & UPJOHN S.P.A. (IT) 2002-06-18 US disclosed